Hepatology Mentorship Program, 31 October – 1 November 2026, Dubai, UAE

Mentorship Program By Invitation Only AIHC Certification

The Future of Liver Medicine

An exclusive regional mentorship program where hepatology expertise, expert mentorship and multidisciplinary collaboration converge to shape the future of liver care in the GCC and Middle East.

Date
31 October – 1 November 2026
Venue and Format
Dubai, United Arab Emirates · In-Person Mentorship Program

Save the date

31 October – 1 November 2026

Dubai, United Arab Emirates · In-Person Mentorship Program

9

Scientific Pillars

5

Core Clinical Themes

GCC

Regional Mentorship Program

CME

Accredited Program

A new kind of program

A mentorship program, not another conference

The Hepatology Mentorship Program is MedicalMinds MEDCOM's flagship hepatology education platform for the GCC and Middle East. Unlike conventional CME meetings, it is designed as an immersive mentorship program combining scientific excellence, expert mentorship, multidisciplinary collaboration, real-world case discussions and practical clinical decision-making.

Mentorship-Driven

Learn directly from leading faculty through structured mentoring, not one-way lectures.

Case-Based Learning

Real-world liver cases, interactive discussion and practical workshops.

Multidisciplinary

Hepatology, imaging, pathology, oncology and transplantation connected around one patient.

Regionally Focused

Evidence-based decision making with a clear focus on implementation across the GCC.

Steering leadership

Chairpersons

The steering committee leads shaping the program's vision.

Dr. Huda Al Quraishi Chairperson

Dr. Huda Al Quraishi

Consultant Gastroenterologist and Hepatologist

Rashid Hospital

Dr. Nawal Al Nahdi Chairperson

Dr. Nawal Al Nahdi

Consultant Gastroenterologist and Hepatologist

Rashid Hospital

Connected liver intelligence

Nine scientific pillars, one liver ecosystem

From metabolic liver disease to transplantation, every pillar stands on its own and feeds the others, spanning the full continuum of modern hepatology.

Metabolic Liver Disease

MASLD and MASH, non-invasive fibrosis assessment, evolving treatment pathways, and smarter patient identification and referral.

Viral Hepatitis

HBV screening, HCV elimination and linkage to care, long-term monitoring, emerging therapies and public health implementation.

Advanced Liver Disease

Cirrhosis, portal hypertension, hepatic encephalopathy and decompensation, with clear referral pathways toward transplantation.

Hepatobiliary Oncology

HCC surveillance, early diagnosis and staging, locoregional and systemic treatment pathways, and longitudinal follow-up.

Autoimmune Liver Diseases

Autoimmune hepatitis and cholestatic liver diseases: early diagnosis, referral criteria and long-term management.

Liver Transplantation

Transplant evaluation and referral timing, candidate selection, and long-term post-transplant care and follow-up.

Hepatobiliary Imaging and Interventional Radiology

Modern liver imaging, standardized reporting and image-guided interventions across benign and malignant disease.

Liver Pathology

Biopsy interpretation, grading and staging, and clinicopathologic correlation that changes management.

Multidisciplinary Liver Cancer Management

Tumor-board decision making uniting hepatology, oncology, radiology, pathology and surgery around one plan.

Strategic framework

The program agenda

The detailed agenda is being finalized with the steering committee. Here is the format the program is built around; the full session-by-session program will be published here.

Scientific Update Lectures

Focused updates on what has changed in hepatology and what it means for the clinic.

Practical Workshops

Small-group, specialist-led workshops built around real-world liver cases.

Multidisciplinary Case Boards

Hepatology, imaging, pathology and transplant perspectives around one patient, one plan.

Mentorship and Expert Panels

Structured mentoring, experience sharing and open ask-the-expert discussion.

The full agenda will be announced soon. Subscribe for updates and it will land in your inbox the moment it is published.

Subscribe

Who should attend

Built for the liver care team

Designed first for hepatologists and gastroenterologists, and open to every specialty involved in the diagnosis, management and follow-up of liver disease.

  • Early-career consultants
  • Mid-career consultants
  • Specialists
  • Fellows and senior residents

Hepatologists

Primary audience

Gastroenterologists

Primary audience

Internal Medicine Physicians

Gastroenterology and Hepatology Fellows

Liver Transplant Physicians

Radiologists

Pathologists

Recognition

Accreditation and certification

CME Accredited

The program is CME accredited. Continuing Medical Education credit details will be shared with the final program.

AIHC Certification

Participants receive a certificate from the American Institute of Healthcare and Hospital Management (AIHC).

Organized by

MedicalMinds MEDCOM

Part of the MM Group